CompletedPhase 4

Premature Discontinuation of Contraceptive Implants

United States600 participantsStarted 2021-06-18

Plain-language summary

To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).

Who can participate

Age range14 Years – 23 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. You are between ages of 14 to 22.9 years.
✓. Started etonogestrel implant for the first time and have never used the implant before.

Exclusion criteria

✕. There is any contraindication to estrogen containing birth control.
✕. Desire of pregnancy in next 12 months.
✕. Plans to move from the area in next 12 months and is not able to come to the clinic.

What they're measuring

Number of Participants With Implant Continuation

Timeframe: 12 months post-insertion

Trial details

NCT IDNCT04828824

SponsorUniversity of Colorado, Denver

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-12

Results submitted2026-02-10

View on ClinicalTrials.gov More Contraception Behavior trials